MNOV
Price
$1.41
Change
+$0.02 (+1.44%)
Updated
Jun 6 closing price
Capitalization
69.16M
62 days until earnings call
VIR
Price
$5.45
Change
+$0.30 (+5.83%)
Updated
Jun 6 closing price
Capitalization
712.62M
54 days until earnings call
Interact to see
Advertisement

MNOV vs VIR

Header iconMNOV vs VIR Comparison
Open Charts MNOV vs VIRBanner chart's image
Medicinova
Price$1.41
Change+$0.02 (+1.44%)
Volume$6.09K
Capitalization69.16M
Vir Biotechnology
Price$5.45
Change+$0.30 (+5.83%)
Volume$1.34M
Capitalization712.62M
MNOV vs VIR Comparison Chart
Loading...
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNOV vs. VIR commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNOV is a Hold and VIR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (MNOV: $1.41 vs. VIR: $5.45)
Brand notoriety: MNOV and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNOV: 45% vs. VIR: 102%
Market capitalization -- MNOV: $69.16M vs. VIR: $712.62M
MNOV [@Biotechnology] is valued at $69.16M. VIR’s [@Biotechnology] market capitalization is $712.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNOV’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • MNOV’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than MNOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNOV’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • MNOV’s TA Score: 4 bullish, 6 bearish.
  • VIR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VIR is a better buy in the short-term than MNOV.

Price Growth

MNOV (@Biotechnology) experienced а +1.44% price change this week, while VIR (@Biotechnology) price change was +10.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

MNOV is expected to report earnings on Aug 08, 2025.

VIR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($713M) has a higher market cap than MNOV($69.2M). VIR YTD gains are higher at: -25.749 vs. MNOV (-32.857). MNOV has higher annual earnings (EBITDA): -12.65M vs. VIR (-598.69M). VIR has more cash in the bank: 802M vs. MNOV (40.4M). MNOV has less debt than VIR: MNOV (194K) vs VIR (96.1M). VIR has higher revenues than MNOV: VIR (14.3M) vs MNOV (0).
MNOVVIRMNOV / VIR
Capitalization69.2M713M10%
EBITDA-12.65M-598.69M2%
Gain YTD-32.857-25.749128%
P/E RatioN/AN/A-
Revenue014.3M-
Total Cash40.4M802M5%
Total Debt194K96.1M0%
FUNDAMENTALS RATINGS
MNOV: Fundamental Ratings
MNOV
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MNOVVIR
RSI
ODDS (%)
Bearish Trend 5 days ago
87%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
71%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 26 days ago
84%
Bearish Trend 24 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGOCX12.27N/A
N/A
PGIM Jennison Global Equity Income C
RYNCX102.82N/A
N/A
Rydex Nova C
LCEYX18.31N/A
N/A
Invesco Diversified Dividend Y
MTCAX61.89N/A
N/A
MFS Technology A
LKSMX11.52N/A
N/A
LKCM Small-Mid Cap Equity Institutional

MNOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNOV has been loosely correlated with FATE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNOV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNOV
1D Price
Change %
MNOV100%
+1.43%
FATE - MNOV
36%
Loosely correlated
+19.40%
MNKD - MNOV
30%
Poorly correlated
+1.86%
ALT - MNOV
30%
Poorly correlated
+2.93%
VIR - MNOV
29%
Poorly correlated
+5.83%
TIL - MNOV
28%
Poorly correlated
+8.44%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+5.83%
SANA - VIR
63%
Loosely correlated
+11.37%
AXON - VIR
47%
Loosely correlated
+1.52%
CPRX - VIR
45%
Loosely correlated
+2.01%
GOSS - VIR
41%
Loosely correlated
+5.56%
IMNM - VIR
41%
Loosely correlated
+0.11%
More